Imara
significant need remains for more treatment options for | Imara
Company
Deck Type
Deck date
October 2022
Slide
20 of 45
Similar slides by Imara
See diffirences between slides (animation)
Mergers and Acquisitions
October 2022
despite great advances a significant need remains for better treatment options for chronic myeloid leukemia | Imara
Related slides by other companies
Aravive
Investor Presentation
September 2022
time on treatment and depth of response for patients and groups i | Aravive
Alkermes
Results
June 2022
artistry in combination with | Alkermes
Equillium
Investor Presentation
February 2024
driving development towards option decision two data deliverables expected in data deliverables and option decision expected during | Equillium
Oculis
Investor Presentation
July 2023
with the potential to address all patients | Oculis
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io